The artemisinins are the cornerstone of current antimalarial treatments. Artesunate is the drug of choice for severe malaria. Artemisinin combination therapies are first-line treatments for uncomplicated falciparum malaria and serve as alternatives to chloroquine for the other types of malaria. These highly effective and well tolerated antimalarials have contributed substantially to global reductions in malaria deaths and complications. The first clear evidence of artemisinin resistance in Plasmodium falciparum parasites came 15 years ago in Western Cambodia. This finding had an ominous precedent. This was the same place from which chloroquine resistance arose first in the late 1950s. Chloroquine resistance, and . . .
Mallika Imwong, Kanokon Suwannasin, Chanon Kunasol, Kreepol Sutawong, Mayfong Mayxay, Rekol Huy, Frank Smithuis, Tin Maung Hlaing, Kyaw Myo Tun, Rob W. van der Pluijm, Rupam Tripura, Olivo Miotto, Didier Ménard, Mehul Dhorda, Nicholas Day, Sir Nicholas White, Arjen M. Dondorp
Shannon Takala‐Harrison, Christopher G. Jacob, Cesar Arze, Michael P. Cummings, Joana C. Silva, Arjen M. Dondorp, Mark M. Fukuda, Tran Tinh Hien, Mayfong Mayxay, Harald Noedl, François Nosten, Myat Phone Kyaw, Thuy-Nhien Nguyen, Mallika Imwong, Delia Bethell, Youry Se, Chanthap Lon, Stuart D. Tyner, David Saunders, Frédéric Ariey, Odile Mercereau‐Puijalon, Didier Ménard, Paul N. Newton, Maniphone Khanthavong,
Sompob Saralamba, Wirichada Pan‐ngum, Richard J. Maude, Sue J. Lee, Joel Tärning, Niklas Lindegårdh, Kesinee Chotivanich, François Nosten, Nicholas P. J. Day, Duong Socheat, Sir Nicholas White, Arjen M. Dondorp, Lisa J. White
Arjen M. Dondorp, François Nosten, Poravuth Yi, Debashish Das, Aung Pyae Phyo, Joel Tärning, Khin Maung Lwin, Frédéric Ariey, Warunee Hanpithakpong, Sue J. Lee, Pascal Ringwald, Kamolrat Silamut, Mallika Imwong, Kesinee Chotivanich, Pharath Lim, Trent Herdman, Sen Sam An, Shunmay Yeung, Pratap Singhasivanon, Nicholas Day, Niklas Lindegårdh, Duong Socheat, Sir Nicholas White
Discussion(0)
No comments yet. Be the first to comment.